High Desert Pathology Medical Group

High Desert Pathology Medical Group was paid $6.35M by Medicaid between Jan 2018 and Dec 2024, across 245 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 14% of everything it billed.

33Billing provider infoHIGH DESERT PATHOLOGY MEDICAL GROUP
VICTORVILLE, CA 92395

33aNPI1407191356assigned 12/04/2012

33bProvider typeAnatomic Pathology & Clinical Pathology Physician

28Total paid$6.35M

24GClaims3,002,598

24DCodes billed245

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in California

Rank by total paid#5 of 222

Median peer was paid$42K

This provider vs. median150×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	490,164	$971K
2019	426,693	$876K
2020	392,456	$850K
2021	475,581	$934K
2022	391,234	$861K
2023	438,263	$990K
2024incomplete	388,207	$868K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
88305	Level IV - Surgical pathology, gross and microscopic examination	14%	22,455	21,835	$905K
80053	Comprehensive metabolic panel	9.4%	344,674	254,942	$598K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	9.0%	468,942	305,483	$571K
88307		6.9%	6,446	6,359	$440K
81025		3.8%	85,251	80,308	$243K
88304		3.8%	10,711	10,475	$240K
80048	Basic metabolic panel (calcium, ionized)	3.0%	141,933	71,805	$192K
83880		2.6%	31,866	27,754	$167K
88342		2.3%	3,701	3,598	$146K
84484		2.1%	87,776	75,517	$136K
84443	Thyroid stimulating hormone (TSH)	2.0%	49,573	46,464	$128K
83735		1.9%	112,384	49,512	$122K

233 more codes

83690		1.7%	101,742	$110K
88313		1.7%	3,224	$107K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.6%	6,077	$103K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.6%	5,085	$100K
82962		1.4%	55,475	$92K
80061	Lipid panel	1.2%	34,457	$74K
83605		1.1%	42,887	$72K
87086	Culture, bacterial; quantitative colony count, urine	1.0%	53,254	$65K
88312		<1%	2,533	$63K
88302		<1%	2,478	$61K
81001		<1%	113,601	$59K
85730		<1%	61,375	$59K
87040		<1%	33,940	$55K
84702		<1%	21,634	$52K
85027		<1%	51,085	$52K
83036	Hemoglobin; glycosylated (A1C)	<1%	34,839	$51K
85610		<1%	75,917	$49K
88341		<1%	970	$47K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	1,152	$47K
87529		<1%	7,509	$41K
84145		<1%	9,963	$41K
84100		<1%	59,005	$38K
81003		<1%	82,687	$30K
80202		<1%	13,661	$30K
84703		<1%	24,928	$29K
82550		<1%	28,807	$28K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	5,578	$27K
87070		<1%	20,406	$27K
87186		<1%	19,632	$26K
87077		<1%	19,800	$25K
82140		<1%	11,091	$25K
84439		<1%	17,960	$25K
87081		<1%	23,207	$25K
86901		<1%	53,489	$24K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	15,804	$24K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,620	$24K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	5,313	$23K
86900		<1%	50,088	$22K
88108		<1%	625	$21K
80074		<1%	2,762	$20K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	4,057	$20K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	3,289	$18K
86780		<1%	8,489	$17K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	3,515	$16K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	4,434	$16K
86850		<1%	28,875	$15K
82150		<1%	13,739	$14K
86140		<1%	17,415	$14K
82247		<1%	17,305	$13K
85379		<1%	7,506	$12K
83021		<1%	4,446	$12K
80076		<1%	9,089	$11K
87210		<1%	4,952	$10K
86880		<1%	11,397	$10K
86141		<1%	5,002	$10K
81002		<1%	25,672	$10K
84480		<1%	4,830	$10K
82553		<1%	5,283	$9K
82803		<1%	4,440	$9K
85378		<1%	8,144	$9K
80320		<1%	5,131	$9K
82248		<1%	13,963	$9K
81000		<1%	16,416	$9K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	6,847	$8K
86710		<1%	2,559	$8K
82728		<1%	4,071	$8K
84481		<1%	2,821	$8K
82805		<1%	1,708	$8K
86803		<1%	3,448	$8K
85384		<1%	5,198	$7K
83615		<1%	8,591	$7K
87340		<1%	4,418	$7K
87430		<1%	4,776	$7K
86762		<1%	3,000	$7K
86592		<1%	9,637	$6K
87486		<1%	1,050	$6K
85007		<1%	10,790	$5K
82746		<1%	2,580	$5K
86703		<1%	2,265	$5K
81015		<1%	12,080	$5K
82948		<1%	8,606	$4K
87205		<1%	6,724	$4K
87581		<1%	1,059	$4K
82607		<1%	1,953	$4K
83540		<1%	4,033	$4K
82570		<1%	4,757	$4K
84436		<1%	4,523	$4K
82077		<1%	332	$4K
84550		<1%	6,336	$4K
83550		<1%	3,094	$4K
82330		<1%	3,585	$4K
87390		<1%	1,243	$4K
80164		<1%	1,696	$4K
88112		<1%	92	$4K
87400		<1%	3,445	$4K
87420		<1%	5,109	$3K
87075		<1%	2,230	$3K
85670		<1%	3,481	$3K
86920		<1%	426	$3K
83874		<1%	1,275	$3K
84156		<1%	4,251	$3K
87510		<1%	717	$3K
87480		<1%	717	$2K
87660		<1%	720	$2K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	114	$2K
86886		<1%	3,250	$2K
83498		<1%	702	$2K
84479		<1%	2,686	$2K
85380		<1%	2,693	$2K
85652		<1%	4,724	$2K
82009		<1%	3,281	$2K
87147		<1%	2,791	$2K
82043		<1%	2,280	$2K
82731		<1%	188	$2K
86885		<1%	2,237	$2K
85651		<1%	4,574	$2K
83789		<1%	643	$2K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	308	$2K
82947		<1%	3,238	$2K
84403		<1%	387	$2K
84300		<1%	1,900	$2K
86403		<1%	871	$2K
88300		<1%	229	$1K
86480		<1%	154	$1K
82261		<1%	569	$1K
85045		<1%	2,093	$1K
86709		<1%	866	$1K
85018		<1%	3,932	$1K
87653		<1%	225	$1K
84132		<1%	2,454	$1K
82565		<1%	1,768	$1K
83516		<1%	832	$1K
82010		<1%	909	$1K
86787		<1%	550	$1K
86706		<1%	679	$1K
83718		<1%	890	$1K
87481		<1%	167	$1K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	182	$1K
86038		<1%	487	$989.40
87116		<1%	565	$969.32
87899		<1%	944	$948.38
86922		<1%	159	$945.97
83930		<1%	871	$928.66
80069		<1%	657	$920.11
84466		<1%	514	$917.62
86870		<1%	303	$907.24
85014		<1%	2,334	$893.77
80329		<1%	244	$891.70
83970		<1%	127	$826.61
82465		<1%	1,288	$824.84
86704		<1%	418	$818.40
82776		<1%	583	$809.33
85060		<1%	72	$805.99
87045		<1%	525	$778.47
88311		<1%	143	$733.35
83721		<1%	552	$697.72
87449		<1%	454	$682.85
87634		<1%	64	$643.44
86756		<1%	297	$628.16
83655		<1%	276	$582.14
84030		<1%	516	$569.45
80047		<1%	373	$563.94
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	227	$525.08
82040		<1%	883	$517.83
84478		<1%	744	$506.82
87101		<1%	372	$483.76
83520		<1%	267	$481.62
87493		<1%	77	$457.85
86677		<1%	218	$445.66
84520		<1%	1,045	$416.94
80185		<1%	186	$382.76
83935		<1%	315	$353.14
80178		<1%	329	$351.54
87220		<1%	142	$344.41
87102		<1%	240	$318.96
86769		<1%	32	$310.52
84153		<1%	95	$298.64
86430		<1%	311	$266.51
85044		<1%	492	$249.84
84450		<1%	530	$245.43
84157		<1%	427	$244.00
82270		<1%	428	$223.53
86593		<1%	308	$218.10
84134		<1%	170	$212.28
87150		<1%	50	$209.33
82945		<1%	334	$200.71
87088		<1%	172	$200.59
86376		<1%	80	$199.76
84460		<1%	445	$190.49
86308		<1%	194	$183.04
85397		<1%	16	$182.62
83001		<1%	55	$179.20
86256		<1%	91	$161.74
84295		<1%	454	$158.54
82670		<1%	28	$137.48
87015		<1%	123	$136.14
86923		<1%	29	$134.59
86705		<1%	59	$122.55
80162		<1%	46	$108.08
86003		<1%	67	$99.05
87324		<1%	48	$97.92
82652		<1%	15	$97.08
80306		<1%	112	$95.69
84144		<1%	25	$90.64
86225		<1%	37	$87.00
86696		<1%	20	$67.70
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	110	$66.00
82533		<1%	27	$64.30
86689		<1%	37	$59.59
82941		<1%	24	$59.44
84133		<1%	81	$57.26
86431		<1%	53	$56.86
87076		<1%	44	$50.64
82272		<1%	47	$45.82
84270		<1%	12	$44.72
82436		<1%	57	$43.31
82274		<1%	14	$36.50
86735		<1%	12	$27.62
86765		<1%	12	$27.26
86160		<1%	13	$27.03
87807		<1%	16	$25.63
85008		<1%	311	$23.34
87184		<1%	28	$22.56
82977		<1%	28	$22.04
84155		<1%	14	$21.63
86702		<1%	12	$19.59
86200		<1%	13	$18.40
80051		<1%	15	$15.94
82784		<1%	12	$14.52
P9011	Blood, split unit	<1%	19	$9.12
99001		0%	60	$0.00
80050	General health panel	0%	38	$0.00
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTADROS, REDA (PRESIDENT)